Shares of Oxford Biomedica plc (OTCMKTS:OXBDF – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $5.30 and last traded at $5.30, with a volume of 110 shares trading hands. The stock had previously closed at $4.92.
Oxford Biomedica Stock Performance
The company has a debt-to-equity ratio of 1.48, a current ratio of 2.35 and a quick ratio of 2.07. The company has a 50-day moving average price of $4.71 and a 200-day moving average price of $4.17.
About Oxford Biomedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Read More
- Five stocks we like better than Oxford Biomedica
- What is the S&P/TSX Index?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Health Care Stocks Explained: Why You Might Want to Invest
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.
